Skip to Main Content

Paper Details

A framework for fibrolamellar carcinoma research and clinical trials.
Nat Rev Gastroenterol Hepatol
18
2022
-, DNAJ, DNAJB1, FLC, FLC tumours, Fibrolamellar carcinoma, HSP40, PKA, PKAc, PRKACA, amino, cancer, cirrhosis, cyclic AMP, cyclic AMP-dependent protein kinase, fibrolamellar carcinoma, heat shock protein 40, hepatic cancer, hepatocellular carcinoma, signature oncogene
Author NameAffiliation
John D GordanUniversity of California at San Francisco Comprehensive Cancer Center
Elizabeth M JaffeeKimmel Comprehensive Cancer Center at Johns Hopkins
Praveen SethupathyCornell University
Praveen SethupathyCornell University
  • 1 - 4

Datasets

Release 1.2